SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000908834-23-000097
Filing Date
2023-08-11
Accepted
2023-08-11 17:17:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 chinook13d.htm SC 13D 1055999
  Complete submission text file 0000908834-23-000097.txt   1057874
Mailing Address C/O FARALLON PARTNERS, L.L.C. ONE MARITIME PLAZA, SUITE 2100 SAN FRANCISCO CA 94111
Business Address C/O FARALLON PARTNERS, L.L.C. ONE MARITIME PLAZA, SUITE 2100 SAN FRANCISCO CA 94111 (415) 421-2132
Farallon Capital Partners, L.P. (Filed by) CIK: 0001175707 (see all company filings)

IRS No.: 943106322 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Subject) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88812 | Film No.: 231165217
SIC: 2834 Pharmaceutical Preparations